Accredo Pays $45M To Escape Novartis Exjade Kickback Suit
Specialty pharmacy Accredo Health Group Inc. agreed to pay $45 million to settle allegations it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp. involving refill prescriptions of an...To view the full article, register now.
Already a subscriber? Click here to view full article